As the cells in our studies were exposed to oestrogen-containing media for a similar length of time and treated with the same NFκB inhibitor at the same dose, it’s possible that JSH-23 (±PEDF) treatment blocked NFκB-mediated apoptosis, resulting in the observed increase in BC cell viability. This evidence concerns the gene NFKB1 and breast cancer.